BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:05 PM
 | 
Feb 25, 2010
 |  BC Extra  |  Company News

FDA extends review for exenatide once weekly

FDA extended the PDUFA date to March 12 from March 5 for an NDA from Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) for exenatide...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >